Melanotan 2

Melanotan 2 is a cyclic heptapeptide containing seven amino acids with structural modifications that improve stability and receptor affinity. The cyclic structure increases resistance to enzymatic degradation and prolongs biological activity. It is synthesized using solid-phase peptide synthesis and purified to research-grade standards.

Melanotan 2 activates melanocortin receptors, particularly MC1R, which regulates melanin production in melanocytes (pigment-producing skin cells). Increased melanin synthesis can darken skin pigmentation and enhance tanning responses. The peptide also interacts with other melanocortin receptors involved in appetite and sexual function.

Melanotan 2 is studied primarily for its pigmentation-related effects and ability to stimulate melanin production. Research has explored its use in photoprotection, tanning response, and melanocortin signaling. Additional studies have investigated effects related to appetite regulation and sexual function.

Reported side effects include nausea, flushing, fatigue, and increased skin pigmentation. Some individuals may develop darkening of freckles or moles due to increased melanin activity. Long-term safety remains under investigation, particularly regarding prolonged melanocortin receptor stimulation.

Melanotan 2 is produced using solid-phase peptide synthesis, where amino acids are assembled sequentially on a resin support. The peptide is cyclized to improve stability and biological activity. After synthesis, it is purified using high-performance liquid chromatography and verified by mass spectrometry.

Melanotan 2 has not been approved by the FDA, EMA, or other major regulatory authorities for therapeutic or cosmetic use. It remains an investigational compound in many regions.

Research and clinical dosing protocols vary depending on study design and intended application. Standardized dosing guidelines have not been established.

• Do follow approved research or clinical protocols.
• Do monitor skin changes during melanocortin-related studies.
  ​
• Don’t combine with other melanocortin agonists without justification.
• Don’t use outside controlled research settings.

• Q: What does Melanotan 2 do?
• A: It stimulates melanocortin receptors involved in melanin production and pigmentation.
  ​
• Q: Is Melanotan 2 the same as Melanotan 1?
• A: No. Although both target melanocortin receptors, Melanotan 2 has broader receptor activity.
  ​
• Q: Why can it darken freckles or moles?
• A: Increased melanin production may enhance pigmentation in existing skin features.